1966 Nobel Prize in Physiology or Medicine — Rous and Huggins: Attacking Cancer from Two Directions, 55 Years Apart

What You Will Learn in This Article

Starting with a chicken with a lump, brought by a farmer from rural Baltimore in 1911, you will understand how Peyton Rous’s discovery of the cancer-causing virus, which was largely ignored for over half a century, eventually led to a Nobel Prize 55 years later. You will also learn about the innovative approach Charles Huggins took in Chicago, using hormonal therapy to treat prostate cancer, the principles behind this treatment, and how the different approaches of these two individuals have shaped the two main pillars of modern oncology.

A Story Different from Common Knowledge: Two Answers to the Cause of Cancer

In the early 20th century, there was no clear answer to the question, "What causes cancer?" Cancer remains a disease that inspires fear, but at that time the cause itself was a mystery. Many scientists were chasing the causes of cancer, but in the 1910s no one yet knew that viruses could be one of them. The reason was simple — viruses could not be observed with an ordinary optical microscope, so no physical basis for such a claim could be secured.

In this context, in 1911 Rous submitted a groundbreaking paper suggesting that viruses could be linked to the development of cancer — and he did so at a time long before the advent of electron microscopy. This claim, made in an era when viruses themselves could not be seen with the eye, was revisited only much later, once the electron microscope had allowed virology to develop empirically. Publishing a paper claiming viruses caused cancer in an age when the objects themselves were invisible — naturally, it was ignored for 55 years.

Huggins attacked cancer from a different angle. His approach was not the identification of causes but the suppression of growth. His treatment showed significant effects in 30-40% of patients. He blocked the recurrence of cancers arising in organs influenced by sex hormones, and, through appropriate hormone-regulating therapy, established a new standard for the treatment of prostate cancer, ovarian cancer, and breast cancer.

The two researchers' work looked unrelated but was in fact bound to a single axis. Rous discovered the Rous sarcoma virus, which causes muscle cancer in birds, and Huggins opened new territory in cancer treatment through hormone therapy for prostate cancer. Their approaches differed, but they were joined under the shared axis of contributing to cancer research — which is what made the joint award possible.

In the language of computer science, the two approaches are as follows: Rous = specific identification of the causal process (Rous sarcoma virus is upstream in the cancer development event), Huggins = suppression of the process by manipulating environmental variables (hormones = reducing the growth trigger to suppress cancer growth).

The Landscape of the Time: Reorganization of Asian Political Entities

1966 was a year when Asian countries fundamentally reshaped their political systems.

In China, the Cultural Revolution began in May. Mao Zedong launched this chaotic period, aiming to eliminate "reactionary academic authorities" and "capitalist tendencies." This upheaval profoundly impacted Chinese society for the next decade. The iconic image of Mao Zedong receiving one million Red Guards in Tiananmen Square in August represents this era. In January, Indira Gandhi became Prime Minister of India, and in March, South Korea signed the Brown Memorandum, finalizing the conditions for U.S. support for the deployment of troops to Vietnam.

In the United States, the Miranda ruling was issued in June — establishing the principle that the rights of arrested persons must be informed to them. This ruling became the foundation of today's criminal procedure.

In this tumultuous year, the Nobel Committee awarded the prize to the author of a paper written 55 years earlier. It was a symbolic moment of a discovery validated a generation later.

Rous — Recognition Delayed by 55 Years

Peyton Rous (1879-1970) was an American pathologist. He earned his medical degree from Johns Hopkins University (1905), briefly taught at the University of Michigan (1906-1908), and in 1908, joined the Rockefeller Institute for Medical Research and remained there until his death, serving for 62 years. His life was characterized by his long service at a single institute.

His discovery story is remarkably simple and human. Rous was born in the rural outskirts of Baltimore, USA, and the story begins when a nearby farmer brought him a chicken with a lump on its chest. Rous crushed the lump and injected it into another chicken — and that chicken developed the same lump. From this measurement he concluded that the extract from the lump contained something that could cause cancer. Later, this "something" was identified as a virus, and the virus was named the Rous sarcoma virus in his honor.

A farmer brought over a chicken with a strange lump, Rous crushed the lump and injected it into another chicken, and that chicken also developed cancer — the entire discovery is honestly at about this level of simplicity. From it he arrived at the conclusion that there was something in the extract that could transmit cancer.

At the time, no one knew what "something" was. Rous's 1911 study of the Rous sarcoma virus went unrecognized for a very long time. Only after the arrival of the electron microscope improved virological methodology did his discovery come back into the light, decades later.

Here is a key fact: Rous died in 1970. The Nobel Prize came in 1966, meaning that his recognition arrived four years before his death, 55 years after the discovery itself. Since Nobel rules do not allow posthumous awards, had he been recognized just four years later, this prize could never have been his.

The Rous sarcoma virus subsequently became the ideal experimental material for verifying that viruses can cause cancer. Compared to other cancer-causing viruses, its process of tumor formation is easier to observe, and because it does not infect humans, experiments carry no danger. Many scientists went on to conduct cancer research using it, and after Rous's paper the field of cancer virology expanded rapidly. Both the 1975 Nobel Prize for "the interaction between cancer-causing viruses and genetic material" (Baltimore, Dulbecco, Temin) and the 1989 Nobel Prize for "the discovery of oncogenes" (Bishop, Varmus) stand on this same lineage.

In other words, Rous's 55-year-ignored paper is itself the root of viral oncology and oncogene research in the second half of the 20th century.

Huggins — Manipulation of Systemic Environmental Variables

Charles B. Huggins (1901-1997) was an American physician. He earned his medical degree from Harvard University (1924) and served as a professor at the University of Chicago (1927-1969) for 42 years, also serving as the director of the University of Chicago's Ben May Cancer Research Institute (1951-1969).

His approach was completely different from Rous. If Rous was focused on identifying the cause, Huggins was focused on finding ways to suppress growth, even without knowing the cause.

He identified a key characteristic of prostate cancer — the growth of prostate tissue is highly dependent on androgens (male hormones). Therefore, if androgens are reduced, the growth of prostate tissue will be suppressed, and the growth of prostate cancer, which is part of the tissue, will also be suppressed. This hypothesis was his key contribution, which he demonstrated clinically.

His treatment produced significant effects in 30–40% of patients. By blocking the recurrence of cancers that arise in organs influenced by sex hormones, and by using appropriate hormone-regulating therapy, Huggins reset the standard of care for prostate cancer, ovarian cancer, and breast cancer — a decisive clinical contribution.

Unrecognized Commit + Environmental Variable Manipulation — CS Framework

The story of this award demonstrates two different principles of computer science.

Rous = the story of an unrecognized commit that is validated 55 years later. This is a common pattern in open-source projects. A developer submits an issue or paper/PR containing a unique observation, but because it cannot be reproduced or verified with the tools of the time, it is ignored. Over time, as tools evolve (in Rous's case, the electron microscope), the observation is revisited and finally recognized. This is the common pattern of delayed recognition of a good idea.

The lesson of this story in computer science: the recognition of the time does not determine the value of an idea. If the observation is accurate, it will be validated when the tools catch up. After publishing his paper, Rous quietly continued his research at the Rockefeller Institute for 55 years. This perseverance eventually led to the award.

Huggins = suppression of a process by manipulating environmental variables. This is a familiar approach in software. If a process depends on a specific environmental variable, the process itself does not need to be modified; the process's behavior can be controlled by changing the environmental variable. This is similar to setting FEATURE_FLAG_X=false in the deployment environment to disable a specific feature.

Prostate cancer = androgen-dependent process. Even if the source code of the process (genetic mutations) is unknown, the process can be weakened by lowering the value of the environmental variable (hormone) that the process depends on. This is why the treatment had an effect in 30-40% of the patients — the degree to which the process depends on the environmental variable varies from patient to patient.

The combination of these two approaches is what we see in modern precision oncology. Identify the causal process (cancer-causing mutations) and then combine it with manipulation of the environmental variables (growth signals, hormones, immune checkpoints) that the process depends on to suppress it. The two pillars laid by Rous and Huggins are integrated half a century later.

Limitations of the analogy: Of course, cancer is a much more complex multi-factorial system than software. There are many mutations, environmental factors, and immune states involved, so it is not possible to conquer all cancers by identifying one cause and manipulating one environmental variable. However, the fundamental strategy of "combining the identification of the cause and the manipulation of the environment" is the same.

Legacy That Continues Today

The impact of the two researchers' work can be framed this way. After Rous's paper, cancer research on the virus–cancer link expanded explosively, and subsequent discoveries by later scientists — such as "the interaction between cancer-causing viruses and genetic material" (1975) and "the discovery of oncogenes" (1989) — went on to earn their own Nobel Prizes. Huggins's hormone-regulating therapy provided the decisive foundation for clarifying the relationship between cancer and sex hormones, and today it anchors the standard of care for breast and prostate cancer.

Today, we see this impact as follows:

• HPV vaccine: With the discovery that 70-90% of cervical cancers are caused by human papillomavirus (HPV) infection, a vaccine has been developed to significantly reduce the incidence of cervical cancer. Rous's discovery 55 years ago is the theoretical basis for this vaccine.
• Treatment of hepatitis B and C to prevent liver cancer: Understanding that chronic hepatitis viruses are major causes of liver cancer has led to antiviral therapies. Today, hepatitis C is a curable disease.
• HTLV-1 adult T-cell leukemia: It has been found that human T-cell leukemia virus is associated with leukemia in certain regions (southern Japan, the Caribbean, etc.).
• Establishment of hormone therapy: Tamoxifen for breast cancer (estrogen receptor-positive) and androgen inhibitors (leuprolide, etc.) for prostate cancer have become standard treatments. Today, millions of people worldwide receive this treatment each year.
• Leading to immune checkpoint inhibitors: Huggins' "environmental variable manipulation" principle has been extended to block the immune checkpoints that tumors evade, allowing the immune system to attack the tumor (2018 Nobel Prize for Allison and Honjo).

Why It Matters

What Rous and Huggins left behind is the fundamental principle that "cancer can be attacked from two directions."

• Causal direction: Identify what causes cancer and block or eliminate the cause.
• Environmental direction: Even if the cause is unknown, manipulate the environment (hormones, growth signals, nutrients) that cancer needs to suppress its growth.

Each approach has its own strengths and weaknesses. The causal approach can provide a fundamental solution, but it is powerless against cancers where the cause is difficult to identify. The environmental approach can be implemented without knowing the cause, but it is powerless against cancers that do not depend on the environment (most advanced cancers). Today, oncology combines these two approaches as appropriate.

This award is a story of an unrecognized commit that is validated 55 years later. It started with a chicken with a lump brought by a farmer from rural Baltimore, and after half a century of perseverance, it became the cornerstone of the entire field of viral oncology. If the observation is accurate, time will eventually validate it — this is the human story of this award.

1966 Rous and Huggins Summary: Rous, who discovered the Rous sarcoma virus in a chicken brought by a farmer in rural Baltimore in 1911, was recognized 55 years later, and his discovery became the cornerstone of viral oncology. Huggins used hormone therapy to treat cancers that depend on sex hormones (prostate cancer, ovarian cancer, breast cancer). This is the theoretical basis for HPV vaccines, tamoxifen, androgen inhibitors, and immune checkpoint inhibitors today.

← Previous: 1965 — Jacob, Lwoff, Monod → Next: 1967 — Granit, Hartline, Wald